MedTrace Logo

Outcome Assessment in Patients Treated With Hyperbaric Oxygen Using OxyVu Tissue Oxygenation Monitoring System

NCT00768027 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2009-06-04

No results posted yet for this study

Summary

The objective is to define patient eligibility for hyperbaric oxygen therapy and to evaluate wound healing progression using a new hyperspectral imaging technology.

Conditions

  • Wounds

Sponsors & Collaborators

  • Hyperbaric and Wound Care Associates

    collaborator UNKNOWN

  • VA Long Beach Healthcare System

    collaborator FED

  • Long Beach Memorial Medical Center

    collaborator OTHER

  • HyperMed

    lead INDUSTRY

Principal Investigators

  • Jeffrey Niezgoda, MD · Hyperbaric & Wound Care Associates

  • Ian L Gordon, MD PhD · VA Long Beach Healthcare System

  • Michael B Strauss, MD · Long Beach Memorial Medical Center

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00768027 on ClinicalTrials.gov